Cargando…

Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data

Model-informed precision dosing is being increasingly used to improve therapeutic drug monitoring. To meet this need, several tools have been developed, but open-source software remains uncommon. Posologyr is a free and open-source R package developed to enable Bayesian individual parameter estimati...

Descripción completa

Detalles Bibliográficos
Autores principales: Leven, Cyril, Coste, Anne, Mané, Camille
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879752/
https://www.ncbi.nlm.nih.gov/pubmed/35214174
http://dx.doi.org/10.3390/pharmaceutics14020442
_version_ 1784658973114236928
author Leven, Cyril
Coste, Anne
Mané, Camille
author_facet Leven, Cyril
Coste, Anne
Mané, Camille
author_sort Leven, Cyril
collection PubMed
description Model-informed precision dosing is being increasingly used to improve therapeutic drug monitoring. To meet this need, several tools have been developed, but open-source software remains uncommon. Posologyr is a free and open-source R package developed to enable Bayesian individual parameter estimation and dose individualization. Before using it for clinical practice, performance validation is mandatory. The estimation functions implemented in posologyr were benchmarked against reference software products on a wide variety of models and pharmacokinetic profiles: 35 population pharmacokinetic models, with 4.000 simulated subjects by model. Maximum A Posteriori (MAP) estimates were compared to NONMEM post hoc estimates, and full posterior distributions were compared to Monolix conditional distribution estimates. The performance of MAP estimation was excellent in 98.7% of the cases. Considering the full posterior distributions of individual parameters, the bias on dosage adjustment proposals was acceptable in 97% of cases with a median bias of 0.65%. These results confirmed the ability of posologyr to serve as a basis for the development of future Bayesian dose individualization tools.
format Online
Article
Text
id pubmed-8879752
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88797522022-02-26 Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data Leven, Cyril Coste, Anne Mané, Camille Pharmaceutics Article Model-informed precision dosing is being increasingly used to improve therapeutic drug monitoring. To meet this need, several tools have been developed, but open-source software remains uncommon. Posologyr is a free and open-source R package developed to enable Bayesian individual parameter estimation and dose individualization. Before using it for clinical practice, performance validation is mandatory. The estimation functions implemented in posologyr were benchmarked against reference software products on a wide variety of models and pharmacokinetic profiles: 35 population pharmacokinetic models, with 4.000 simulated subjects by model. Maximum A Posteriori (MAP) estimates were compared to NONMEM post hoc estimates, and full posterior distributions were compared to Monolix conditional distribution estimates. The performance of MAP estimation was excellent in 98.7% of the cases. Considering the full posterior distributions of individual parameters, the bias on dosage adjustment proposals was acceptable in 97% of cases with a median bias of 0.65%. These results confirmed the ability of posologyr to serve as a basis for the development of future Bayesian dose individualization tools. MDPI 2022-02-18 /pmc/articles/PMC8879752/ /pubmed/35214174 http://dx.doi.org/10.3390/pharmaceutics14020442 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Leven, Cyril
Coste, Anne
Mané, Camille
Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data
title Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data
title_full Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data
title_fullStr Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data
title_full_unstemmed Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data
title_short Free and Open-Source Posologyr Software for Bayesian Dose Individualization: An Extensive Validation on Simulated Data
title_sort free and open-source posologyr software for bayesian dose individualization: an extensive validation on simulated data
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8879752/
https://www.ncbi.nlm.nih.gov/pubmed/35214174
http://dx.doi.org/10.3390/pharmaceutics14020442
work_keys_str_mv AT levencyril freeandopensourceposologyrsoftwareforbayesiandoseindividualizationanextensivevalidationonsimulateddata
AT costeanne freeandopensourceposologyrsoftwareforbayesiandoseindividualizationanextensivevalidationonsimulateddata
AT manecamille freeandopensourceposologyrsoftwareforbayesiandoseindividualizationanextensivevalidationonsimulateddata